about
Antiretroviral medication: an emerging category of prescription drug misuseThe dual modulatory effects of efavirenz on GABAA receptors are mediated via two distinct sites.No Evidence of an Association Between Efavirenz Exposure and Suicidality Among HIV Patients Initiating Antiretroviral Therapy in a Retrospective Cohort Study of Real World Data.The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk.Potential benefits of cyproheptadine in HIV-positive patients under treatment with antiretroviral drugs including efavirenz.Prescription medication misuse among HIV-infected individuals taking antiretroviral therapyOnce-Daily, Single-Tablet Regimens For the Treatment of HIV-1 InfectionThe Expanding Class of Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of HIV-1 InfectionIncidence and predictors of adverse drug events in an African cohort of HIV-infected adults treated with efavirenz.Atriplatrade mark - HIV therapy in one pill.Efavirenz: a decade of clinical experience in the treatment of HIV.Implications of efavirenz for neuropsychiatry: a review.Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 - 2010).Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics.Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.Tolerance of the newborn to antiretroviral drug exposure in utero.Efavirenz alters mitochondrial respiratory function in cultured neuron and glial cell lines.Postexposure Prophylaxis Against Human Immunodeficiency Virus (HIV): New Guidelines From the WHO: A Perspective.Efficacy and safety 48 weeks after switching from efavirenz to rilpivirine using emtricitabine/tenofovir disoproxil fumarate-based single-tablet regimens.Depressive symptoms and exposure to efavirenz in West African HIV-infected adults.Depression associated with antiretroviral drug therapy in HIV: case report and overview.Incidence and risk factors for neuropsychiatric events among Ghanaian HIV patients on long-term non-nucleoside reverse transcriptase inhibitor-based therapy.Understanding the impact of HIV diagnosis amongst gay men in Scotland: an interpretative phenomenological analysis.Incidence of neuropsychiatric side effects of efavirenz in HIV-positive treatment-naïve patients in public-sector clinics in the Eastern Cape.HIV and mental illness in Malawi and the neuropsychiatric sequelae of efavirenz.
P2860
Q26852974-EB676020-8E22-4D15-868F-2BCBDFFF6F5FQ30401509-489E3BC5-8840-4C25-899C-A82E40D4412BQ31040458-3939AD04-F89D-4B20-B979-98DE0FE1D3D0Q33849136-4DC26EB2-7D39-4314-8353-F76A04E5CBE0Q34310827-64EBC9E9-9A64-4EFA-970C-5B0D13820C43Q34602717-9753B394-E428-40EE-8D27-369B641DD3F2Q34976284-9D0F6DD5-BBD3-4CF5-8938-B3A501F8D35EQ35111300-008AC9B6-2393-4972-B663-A9FC3CFE05DBQ36062320-3D56407D-C097-45DE-8FE4-374E756F0FACQ36818184-B9B4191F-6D91-49EA-B53B-AE6CC0A75070Q37383949-FFDE8CF9-5018-4994-8476-07DD2C004714Q37801927-451CF00B-C65A-44B9-924D-917CEFB1C8B3Q37860335-F1032FA5-7EC3-41B9-9659-884DC3E9E985Q37866298-D4B77875-673B-4071-806F-C08F308044B3Q37900614-142FF43D-0AE0-48C9-B476-F8D6CD336355Q38366365-3AAC056D-38CA-430D-8005-402D356D8406Q38880828-0459D659-93F7-49FF-AA5B-F3B66D28BF54Q41233086-6026AA7A-9466-4520-A733-2B3E787192D7Q42260844-FDC0FA3D-8AAF-4199-B49F-CFCA85C218AEQ46127982-E31AA279-56F4-4BB2-9F5E-3940141A6CCCQ48642405-9384E2F2-BFCB-4270-9295-1B66D8DA0179Q50028053-F87B19D9-75FF-413E-9EF9-AEF42A6131ADQ50605071-7860AE19-47F9-4E16-B009-CE05209A683FQ53759304-A5BF728C-940B-45B0-80A8-1B230C358FB7Q55344050-F21DC4AB-2649-4ED3-89A9-645BE7CF1C89
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Neuropsychiatric side effects of efavirenz therapy.
@ast
Neuropsychiatric side effects of efavirenz therapy.
@en
type
label
Neuropsychiatric side effects of efavirenz therapy.
@ast
Neuropsychiatric side effects of efavirenz therapy.
@en
prefLabel
Neuropsychiatric side effects of efavirenz therapy.
@ast
Neuropsychiatric side effects of efavirenz therapy.
@en
P2093
P2860
P356
P1476
Neuropsychiatric side effects of efavirenz therapy.
@en
P2093
Dominique de Nocker
Gabriele Arendt
Hans-Juergen von Giesen
Thorsten Nolting
P2860
P304
P356
10.1517/14740338.6.2.147
P407
P577
2007-03-01T00:00:00Z